HDAC3 in action: Expanding roles in inflammation and inflammatory diseases

Ruyuan He , Zhuokun He , Tianyu Zhang , Bohao Liu , Minglang Gao , Ning Li , Qing Geng

Cell Proliferation ›› 2025, Vol. 58 ›› Issue (1) : e13731

PDF
Cell Proliferation ›› 2025, Vol. 58 ›› Issue (1) : e13731 DOI: 10.1111/cpr.13731
REVIEW

HDAC3 in action: Expanding roles in inflammation and inflammatory diseases

Author information +
History +
PDF

Abstract

Inflammation serves as the foundation for numerous physiological and pathological processes, driving the onset and progression of various diseases. Histone deacetylase 3 (HDAC3), an essential chromatin-modifying protein within the histone deacetylase superfamily, exerts its transcriptional inhibitory role through enzymatic histone modification to uphold normal physiological function, growth, and development of the body. With both enzymatic and non-enzymatic activities, HDAC3 plays a pivotal role in regulating diverse transcription factors associated with inflammatory responses and related diseases. This review examines the involvement of HDAC3 in inflammatory responses while exploring its therapeutic potential as a target for treating inflammatory diseases, thereby offering valuable insights for clinical applications.

Cite this article

Download citation ▾
Ruyuan He, Zhuokun He, Tianyu Zhang, Bohao Liu, Minglang Gao, Ning Li, Qing Geng. HDAC3 in action: Expanding roles in inflammation and inflammatory diseases. Cell Proliferation, 2025, 58(1): e13731 DOI:10.1111/cpr.13731

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.

AI Summary AI Mindmap
PDF

95

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/